Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Revenues:
Total revenues	$ 48,611	$ 18,894	$ 89,237	$ 30,886
Expenses:
Cost of goods sold	5,224	4,617	10,754	6,901
Research and development	6,453	4,893	12,058	8,429
Selling	14,002	15,868	27,312	28,596
General and administrative	11,947	10,175	22,489	18,144
Loss (gain) on foreign currency transaction	251	(4,503)	1,205	(6,486)
Total expenses	46,890	39,348	93,514	72,596
Income (loss) from operations	1,721	(20,454)	(4,277)	(41,710)
Other income (expense):
Interest income, net	1,547	516	2,849	893
Interest expense on financing liability	(2,449)	(2,443)	(4,873)	(4,814)
Interest expense	(6,873)	(6,642)	(9,659)	(9,390)
Gain on available-for-sale securities	932		932
Other expense	(143)		(32)
Total other expense	(6,986)	(8,569)	(10,783)	(13,311)
Loss before income tax expense	(5,265)	(29,023)	(15,060)	(55,021)
Benefit from income taxes	0	0	0	0
Net loss	$ (5,265)	$ (29,023)	$ (15,060)	$ (55,021)
Net loss per share - basic	$ (0.02)	$ (0.11)	$ (0.06)	$ (0.22)
Net loss per share - diluted	$ (0.02)	$ (0.11)	$ (0.06)	$ (0.22)
Weighted average shares used to compute net loss per share - basic	265,626	253,644	264,802	252,775
Weighted average shares used to compute net loss per share - diluted	265,626	253,644	264,802	252,775
Commercial product sales
Revenues:
Total revenues	$ 18,345	$ 12,722	$ 35,907	$ 22,548
Collaborations and services
Revenues:
Total revenues	11,211	5,868	22,597	8,034
Expenses:
Cost of revenue	9,013	8,298	19,696	17,012
Royalties collaborations
Revenues:
Total revenues	$ 19,055	$ 304	$ 30,733	$ 304